Summary:
Click image to enlargeThe AIM-PMR Study is evaluating an investigational medication to see if it may alleviate symptoms of polymyalgia rheumatica (PMR) in people with PMR who are currently taking a type of medication called glucocorticoids (such as prednisone).
Criteria:• Are at least 50 years old
• Have been diagnosed with PMR
• Experienced improvement in their PMR symptoms with prednisone or other oral steroid medication
• Have had a flare (recurrence of symptoms) while being treated for PMR
There are other requirements that the study team will discuss with you and your loved one to determine if they
are eligible to participate.
Qualified Participants May Receive:
- Study medication and study medical care at no cost
- Compensation for time and travel